PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
High-dose pawpaw seed extract (500 mg/kg) significantly decreased body weight and visceral fat mass in high-fat diet-induced obese mice [PMID:40869040].
A polysaccharide from the fruit (ATP-W-1) ameliorated symptoms in DSS-induced colitis mice by modulating gut microbiota and restoring epithelial barrier integrity [PMID:41266375].
Extracts from twigs and unripe fruit inhibited the growth of gastric (AGS) and cervical (HeLa) cancer cells [PMID:33630206, PMID:29660776]. Annonacin inhibited ovarian cancer cell viability and synergistically enhanced the efficacy of carboplatin [PMID:40618909].
Unripe pawpaw used as an enzymatic debriding agent in 30 patients with lower extremity wounds resulted in eschar separation between 3 and 14 days [PMID:35592226].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36330137 (2022) — Physical characterization of frozen fruits from eight cultivars of the North American pawpaw (Asimina triloba). · Frontiers in nutrition
- 2.PMID: 36858541 (2023) — Effects of Pawpaw (Asimina triloba) Seed Extract on the Differentiation and Fat Accumulation of 3T3-L1 Cells under Different Glucose Conditions. · Journal of nutritional science and vitaminology
- 3.PMID: 29217674 (2017) — Pollen-pistil interaction in pawpaw (Asimina triloba), the northernmost species of the mainly tropical family Annonaceae. · American journal of botany
- 4.PMID: 40869040 (2025) — Pawpaw (Asimina triloba) Seed Extract Suppresses High-Fat Diet-Induced Obesity in Mice. · International journal of molecular sciences
- 5.PMID: 30453785